GENEVA, Feb. 18 -- DEBUT BIOTECHNOLOGY, INC. (11545 Sorrento Valley Rd., Suite 310San Diego, CA 92121) filed a patent application (PCT/US2024/041661) for "FORMULATIONS OF ERIODICTYOL" on Aug 09, 2024. With publication no. WO/2025/035070, the details related to the patent application was published on Feb 13, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): OSWALD, Taylor (100 Park Plaza, #417San Diego, CA 92101)
Abstract:
The invention provides compositions comprising eriodictyol. The compositions of the invention may be administered topically, on the skin of the subject. The invention furt...